enzo biochem inc
(ENZ:New York Consolidated)
Bruce Taillon Ph.D.
Head of Global Technology Business Development, Enzo Biochem Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
Dr. Bruce Taillon, PhD. has been Head of Global Technology Business Development at Enzo Biochem Inc. and Enzo Life Sciences, Inc. since August 2011. Dr. Taillon served at Roche Diagnostics' 454 Life Sciences Division, where he was responsible for world-wide business development efforts centered around the company's next generation nucleic acid sequencing platform and its potential use in diagnostic assays. He also has experience in leading R&D teams focused in the areas ...
527 Madison AvenuePhone: 212-583-0100
New York, New York 10022
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Justin C. Dearborn||Chief Executive Officer, President, Corporate Secretary, Director, Member of Executive Committee and Chief Executive Officer of Merge DNA|
Merge Healthcare Incorporated
|Robert A. Frist Jr.||Co-Founder, Chairman of the Board, Chief Executive Officer and President|
|Franklin R. Witney Ph.D.||Chief Executive Officer, President and Director|
|Patrick J. Balthrop Sr.||Chief Executive Officer, President, Director, Member of Executive Committee and Member of Strategy & Development Committee|
|J. Boyd Douglas||Chief Executive Officer, President and Executive Director|
Computer Programs & Systems Inc.
|$600.0K||Compensation as of Fiscal Year 2013.|